Vena Cava Thrombosis after Congenital Diaphragmatic Hernia Repair: Multivariate Analysis of Potential Risk Factors

Abstract

Introduction The treatment of newborns with congenital diaphragmatic hernia (CDH) is associated with a significant complication rate. Information on major thrombotic complications and their incidence in newborns with CDH is lacking. The aims of our analysis were to evaluate the frequency of vena cava thrombosis and to determine its predictors within a consecutive series of patients with CDH.

Materials and Methods We retrospectively analyzed charts of all neonates of our department that underwent CDH repair from 2007 to 2021, focusing on vena cava thrombosis. Vena cava thrombosis was diagnosed sonographically and classified as complete or partial venous occlusion. Complete occlusion was confirmed by cavography. Variables evaluated were CDH side, liver position, central vein line, surgical approach, and extracorporeal membrane oxygenation (ECMO). Univariate and multivariate tests were utilized.

Results Among 57 neonates who underwent CDH repair, vena cava thrombosis was diagnosed in 14 (24.6%), seven of whom had complete occlusion of the vena cava. Factors associated with vena cava thrombosis were femoral or saphenous venous catheter (p = 0.044), right sided CDH (p = 0.027) and chylothorax (p < 0.0001). ECMO was not associated with vena cava thrombosis. Seven patients (50%) with vena cava thrombosis were treated interventionally with angioplasty and seven (50%) conservatively with anticoagulation only. Mortality was not higher in patients with compared with patients without vena cava thrombosis.

Conclusion The incidence of vena cava thrombosis in newborns with CDH in our series is high. Routine postoperative abdominal sonography focusing on vena cava thrombosis is mandatory in all patients with CDH. Patients who developed vena cava thrombosis were more likely to develop chylothorax after CDH repair. Considering the good outcome of medical therapy of partial vena cava thrombosis, it may be discussed whether low dose anticoagulation may be provided to all newborns with CDH.

Keywords

congenital diaphragmatic hernia - vena cava thrombosis - predicting risk factors - regression model

Publikationsverlauf

Eingereicht: 18. Juli 2021

Angenommen: 01. November 2021

Artikel online veröffentlicht:
10. Dezember 2021

• References

• 1 Puligandla PS, Skarsgard ED. The Canadian Pediatric Surgery Network Congenital Diaphragmatic Hernia Evidence Review Project: developing national guidelines for care. Paediatr Child Health 2016; 21 (04) 183-186
• 2 Puligandla PS, Skarsgard ED, Offringa M. et al; Canadian Congenital Diaphragmatic Hernia Collaborative. Diagnosis and management of congenital diaphragmatic hernia: a clinical practice guideline. CMAJ 2018; 190 (04) E103-E112
• 3 Chiu PPL, Sauer C, Mihailovic A. et al. The price of success in the management of congenital diaphragmatic hernia: is improved survival accompanied by an increase in long-term morbidity?. J Pediatr Surg 2006; 41 (05) 888-892
• 4 Snoek KG, Reiss IKM, Greenough A. et al; CDH EURO Consortium. Standardized postnatal management of infants with congenital diaphragmatic hernia in Europe: The CDH EURO Consortium Consensus - 2015 update. Neonatology 2016; 110 (01) 66-74
• 5 Levy SM, Lally PA, Lally KP, Tsao K. Congenital Diaphragmatic Hernia Study Group. The impact of chylothorax on neonates with repaired congenital diaphragmatic hernia. J Pediatr Surg 2013; 48 (04) 724-729
• 6 Morini F, Lally PA, Lally KP, Bagolan P. The Congenital Diaphragmatic Hernia Study Group Registry. Eur J Pediatr Surg 2015; 25 (06) 488-496
• 7 Zani A, Eaton S, Puri P. et al; EUPSA Network Office. International survey on the management of congenital diaphragmatic hernia. Eur J Pediatr Surg 2016; 26 (01) 38-46
• 8 Haley KM. Neonatal venous thromboembolism. Front Pediatr 2017; 5: 136
• 9 Bhat R, Kumar R, Kwon S, Murthy K, Liem RI. Risk factors for neonatal venous and arterial thromboembolism in the neonatal intensive care unit-a case control study. J Pediatr 2018; 195: 28-32
• 10 Häusler M, Hübner D, Delhaas T, Mühler EG. Long term complications of inferior vena cava thrombosis. Arch Dis Child 2001; 85 (03) 228-233
• 11 Tieu P, Paes B, Ahmed A, Matino D, Chan A, Bhatt M. Inferior vena cava syndrome in neonates: an evidence-based systematic review of the literature. Pediatr Blood Cancer 2020; 67 (04) e28114
• 12 Nossair F, Schoettler P, Starr J. et al. Pediatric superior vena cava syndrome: An evidence-based systematic review of the literature. Pediatr Blood Cancer 2018; 65 (09) e27225
• 13 Kumar TKS, Subramanian S, Sathanandam S, Alexander J, Ali M, Knott-Craig CJ. Superior vena cava reconstruction for treatment of chylothorax resulting from thrombosis of superior vena cava in young infants. Ann Thorac Surg 2015; 100 (04) 1432-1436
• 14 Romantsik O, Bruschettini M, Zappettini S, Ramenghi LA, Calevo MG. Heparin for the treatment of thrombosis in neonates. Cochrane Database Syst Rev 2016; 11 (11) CD012185
• 15 Veldman A, Nold MF, Michel-Behnke I. Thrombosis in the critically ill neonate: incidence, diagnosis, and management. Vasc Health Risk Manag 2008; 4 (06) 1337-1348
• 16 Mehta S, Connors Jr. AF, Danish EH, Grisoni E. Incidence of thrombosis during central venous catheterization of newborns: a prospective study. J Pediatr Surg 1992; 27 (01) 18-22
• 17 Ross Jr. P, Ehrenkranz R, Kleinman CS, Seashore JH. Thrombus associated with central venous catheters in infants and children. J Pediatr Surg 1989; 24 (03) 253-256
• 18 Zöller B, Li X, Sundquist J, Sundquist K, Crump C. Gestational age and risk of venous thromboembolism from birth through young adulthood. Pediatrics 2014; 134 (02) e473-e480
• 19 Schmidt B. The etiology, diagnosis and treatment of thrombotic disorders in newborn infants: a call for international and multi-institutional studies. Semin Perinatol 1997; 21 (01) 86-89
• 20 Hinson RM, Naulty C. Use of central venous catheters is common in neonatal intensive care units. J Perinatol 1995; 15 (06) 519
• 21 Massicotte MP, Dix D, Monagle P, Adams M, Andrew M. Central venous catheter related thrombosis in children: analysis of the Canadian Registry of Venous Thromboembolic Complications. J Pediatr 1998; 133 (06) 770-776
• 22 Park CK, Paes BA, Nagel K, Chan AK, Murthy P. Thrombosis and Hemostasis in Newborns (THiN) Group. Neonatal central venous catheter thrombosis: diagnosis, management and outcome. Blood Coagul Fibrinolysis 2014; 25 (02) 97-106
• 23 Butler-O'Hara M, Buzzard CJ, Reubens L, McDermott MP, DiGrazio W, D'Angio CT. A randomized trial comparing long-term and short-term use of umbilical venous catheters in premature infants with birth weights of less than 1251 grams. Pediatrics 2006; 118 (01) e25-e35
• 24 Narang S, Roy J, Stevens TP, Butler-O'Hara M, Mullen CA, D'Angio CT. Risk factors for umbilical venous catheter-associated thrombosis in very low birth weight infants. Pediatr Blood Cancer 2009; 52 (01) 75-79
• 25 Kim JH, Lee YS, Kim SH, Lee SK, Lim MK, Kim HS. Does umbilical vein catheterization lead to portal venous thrombosis? Prospective US evaluation in 100 neonates. Radiology 2001; 219 (03) 645-650
• 26 Boo NY, Wong NC, Zulkifli SS, Lye MS. Risk factors associated with umbilical vascular catheter-associated thrombosis in newborn infants. J Paediatr Child Health 1999; 35 (05) 460-465
• 27 van Ommen CH, Heijboer H, Büller HR, Hirasing RA, Heijmans HS, Peters M. Venous thromboembolism in childhood: a prospective two-year registry in The Netherlands. J Pediatr 2001; 139 (05) 676-681
• 28 Lally KP, Lally PA, Van Meurs KP. et al; Congenital Diaphragmatic Hernia Study Group. Treatment evolution in high-risk congenital diaphragmatic hernia: ten years' experience with diaphragmatic agenesis. Ann Surg 2006; 244 (04) 505-513
• 29 Lally KP, Lally PA, Lasky RE. et al; Congenital Diaphragmatic Hernia Study Group. Defect size determines survival in infants with congenital diaphragmatic hernia. Pediatrics 2007; 120 (03) e651-e657
• 30 Kamdar A, Rintoul N, Raffini L. Anticoagulation in neonatal ECMO. Semin Perinatol 2018; 42 (02) 122-128
• 31 Brindle ME, Brar M, Skarsgard ED. Canadian Pediatric Surgery Network (CAPSNet). Patch repair is an independent predictor of morbidity and mortality in congenital diaphragmatic hernia. Pediatr Surg Int 2011; 27 (09) 969-974
• 32 Daodu O, Brindle ME. Predicting outcomes in congenital diaphragmatic hernia. Semin Pediatr Surg 2017; 26 (03) 136-139
• 33 Tuckuviene R, Christensen AL, Helgestad J, Johnsen SP, Kristensen SR. Pediatric venous and arterial noncerebral thromboembolism in Denmark: a nationwide population-based study. J Pediatr 2011; 159 (04) 663-669
• 34 Andrew M, Paes B, Milner R. et al. Development of the human coagulation system in the healthy premature infant. Blood 1988; 72 (05) 1651-1657
• 35 Kenet G, Cohen O, Bajorat T, Nowak-Göttl U. Insights into neonatal thrombosis. Thromb Res 2019; 181 (Suppl. 01) S33-S36
• 36 Prodhan P, Mathur M. Intra-Abdominal Pressure Monitoring in Neonates. Pediatr Crit Care Med 2016; 17 (02) 172-173
• 37 Kaussen T, Gutting M, Lasch F. et al. Continuous intra-gastral monitoring of intra-abdominal pressure in critically ill children: a validation study. Intensive Care Med Exp 2021; 9 (01) 24
• 38 Kiblawi R, Zoeller C, Zanini A. et al. Video-assisted thoracoscopic or conventional thoracic surgery in infants and children: current evidence. Eur J Pediatr Surg 2021; 31 (01) 54-64
• 39 Downey R. Anatomy of the normal diaphragm. Thorac Surg Clin 2011; 21 (02) 273-279
• 40 Gonzalez R, Bryner BS, Teitelbaum DH, Hirschl RB, Drongowski RA, Mychaliska GB. Chylothorax after congenital diaphragmatic hernia repair. J Pediatr Surg 2009; 44 (06) 1181-1185 , discussion 1185
• 41 Kamiyama M, Usui N, Tani G. et al. Postoperative chylothorax in congenital diaphragmatic hernia. Eur J Pediatr Surg 2010; 20 (06) 391-394
• 42 Costa KM, Saxena AK. Surgical chylothorax in neonates: management and outcomes. World J Pediatr 2018; 14 (02) 110-115
• 43 Tutor JD. Chylothorax in infants and children. Pediatrics 2014; 133 (04) 722-733
• 44 Naik S, Greenough A, Zhang YX, Davenport M. Prediction of morbidity during infancy after repair of congenital diaphragmatic hernia. J Pediatr Surg 1996; 31 (12) 1651-1654
• 45 Riley LE, Ataya A. Clinical approach and review of causes of a chylothorax. Respir Med 2019; 157: 7-13
• 46 Klin B, Kohelet D, Bar-Nathan N, Goldberg M, Vinograd I. Chylothorax complicating repair of congenital diaphragmatic hernia. Isr J Med Sci 1992; 28 (12) 891-892
• 47 Trevisanuto D, Chiandetti L, Biban P, Zanardo V. Chylothorax complicating ECMO and surgical repair of congenital diaphragmatic hernia. Isr J Med Sci 1995; 31 (06) 388-389
• 48 Berman Jr. W, Fripp RR, Yabek SM, Wernly J, Corlew S. Great vein and right atrial thrombosis in critically ill infants and children with central venous lines. Chest 1991; 99 (04) 963-967
• 49 Gohar A, Jamous F, Meyer N. Chylothorax as a complication of extensive spontaneous left arm DVT. BMJ Case Rep 2019; 12 (12) e232563
• 50 Monagle P, Newall F. Management of thrombosis in children and neonates: practical use of anticoagulants in children. Hematology (Am Soc Hematol Educ Program) 2018; 2018 (01) 399-404
• 51 Monagle P, Cuello CA, Augustine C. et al. American Society of Hematology 2018 Guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism. Blood Adv 2018; 2 (22) 3292-3316